Evidence map›Paper›PMID 35756601›Full record

ArticleFrontiers in oncology2022

Construction of ceRNA Networks Associated With CD8 T Cells in Breast Cancer.

Zhilin Chen, Ruifa Feng, Ulf Dietrich Kahlert, Zhitong Chen, Luz Angela Torres-Dela Roche, Amr Soliman, Chen Miao, Rudy Leon De Wilde, Wenjie Shi

Abstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Cancers · 2024
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhilin ChenDepartment of Breast and Thoracic Oncological Surgery, The First Affiliated Hospital of Hainan Medical University, Haikou, China.
Ruifa FengBreast Center of The Second Affiliated Hospital of Guilin Medical University, Guilin, China.
Ulf Dietrich KahlertMolecular and Experimental Surgery, University Clinic for General-, Visceral- and Vascular Surgery, University Medicine Magdeburg and Otto-von Guericke University, Magdeburg, Germany.
Zhitong ChenUniversity Hospital for Gynecology, Pius-Hospital, University Medicine Oldenburg, Oldenburg, Germany.
Luz Angela Torres-Dela RocheUniversity Hospital for Gynecology, Pius-Hospital, University Medicine Oldenburg, Oldenburg, Germany.
Amr SolimanUniversity Hospital for Gynecology, Pius-Hospital, University Medicine Oldenburg, Oldenburg, Germany.
Chen MiaoDepartment of Pathology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Rudy Leon De WildeUniversity Hospital for Gynecology, Pius-Hospital, University Medicine Oldenburg, Oldenburg, Germany.
Wenjie ShiUniversity Hospital for Gynecology, Pius-Hospital, University Medicine Oldenburg, Oldenburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The infiltration of CD8 T cells is usually linked to a favorable prognosis and may predict the therapeutic response of breast cancer patients to immunotherapy. The purpose of this research is to investigate the competing endogenous RNA (ceRNA) network correlated with the infiltration of CD8 T cells. Methods: Based on expression profiles, CD8 T cell abundances for each breast cancer (BC) patient were inferred using the bioinformatic method by immune markers and expression profiles. We were able to extract the differentially expressed RNAs (DEmRNAs, DEmiRNAs, and DElncRNAs) between low and high CD8 T-cell samples. The ceRNA network was constructed using Cytoscape. Machine learning models were built by lncRNAs to predict CD8 T-cell abundances. The lncRNAs were used to develop a prognostic model that could predict the survival rates of BC patients. The expression of selected lncRNA (XIST) was validated by quantitative real-time PCR (qRT-PCR). Results: A total of 1,599 DElncRNAs, 89 DEmiRNAs, and 1,794 DEmRNAs between high and low CD8 T-cell groups were obtained. Two ceRNA networks that have positive or negative correlations with CD8 T cells were built. Among the two ceRNA networks, nine lncRNAs (MIR29B2CHG, NEAT1, MALAT1, LINC00943, LINC01146, AC092718.4, AC005332.4, NORAD, and XIST) were selected for model construction. Among six prevalent machine learning models, artificial neural networks performed best, with an area under the curve (AUC) of 0.855. Patients from the high-risk category with BC had a lower survival rate compared to those from the low-risk group. The qRT-PCR results revealed significantly reduced XIST expression in normal breast samples, which was consistent with our integrated analysis. Conclusion: These results potentially provide insights into the ceRNA networks linked with T-cell infiltration and provide accurate models for T-cell prediction.

Indexed as

breast cancerceRNAlncRNAtargetT cell

Identifiers

PMID35756601
PMCPMC9219915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.